1
submitted 4 months ago* (last edited 3 days ago) by [email protected] to c/[email protected]

A graduate of the University of Melbourne, Dr Sikaris trained at the Royal Melbourne, Queen Victoria, and Prince Henry's Heidelberg Repatriation Hospitals. He obtained fellowships from the Royal College of Pathologists of Australasia and the Australasian Association of Clinical Biochemists in 1992 and 1997 respectively.

Dr Sikaris was Director of Chemical Pathology at St Vincent's Hospital in Melbourne between 1993 and 1996. A NATA-accredited laboratory assessor, Dr Sikaris specialises in Prostate Specific Antigen, cholesterol and quality assurance and is currently chair of the International Federation of Clinical Chemistry Committee on Analytical Quality. His expertise is highly sought and he has presented extensively at national and international symposiums.

summerizer

A/Prof. Ken Sikaris - 'Analysing The Cholesterol Message'

In this enlightening lecture, A/Prof. Ken Sikaris discusses the complexities of cholesterol, triglycerides, and their relationship to diet, particularly low-carb diets. Drawing on his extensive research and clinical experience, he emphasizes the importance of understanding different types of LDL (low-density lipoprotein) and their implications for cardiovascular health. He critiques traditional views on cholesterol and advocates for a more nuanced understanding of lipid profiles, with a special focus on the role of diet in influencing these markers. Dr. Sikaris presents evidence supporting low-carb diets as beneficial for managing cholesterol levels and reducing the risk of fatty liver disease, while also explaining the biochemical mechanisms behind these changes.

Key Points

Introduction to Cholesterol Research

A/Prof. Ken Sikaris shares his background and initial interest in cholesterol management. He recounts how his own poor health metrics in 1989 spurred his deeper investigation into cholesterol types, which led to significant findings regarding small dense LDL and its association with cardiovascular diseases.

Evolution of Dietary Perspectives

In 2008, Robert Lustig's lecture catalyzed a shift in how scientists and clinicians viewed carbohydrates and their impact on health, particularly regarding sugar and fructose. Dr. Sikaris reflects on how these insights influenced his own dietary choices and professional focus.

Impact of Low Carb Diets on Lipid Profiles

Research indicates that low-carb diets can significantly improve lipid profiles by lowering triglycerides and increasing HDL (the 'good' cholesterol), providing a more beneficial total cholesterol/HDL ratio compared to high-carb diets.

Fructose and Fat Accumulation

Dr. Sikaris discusses how high fructose intake correlates with increased triglycerides and fatty liver disease. He notes that while glucose may not convert to fat in the same way, fructose promotes fat accumulation more readily.

Importance of Triglyceride Measurements

Triglycerides serve as a crucial indicator for predicting fatty liver development and cardiovascular risk. Dr. Sikaris emphasizes the utility of triglyceride levels over traditional cholesterol measures for assessing metabolic health.

Insights from Recent Studies

Dr. Sikaris reviews various studies demonstrating that high-carb diets may lower LDL but also reduce HDL, while low-carb approaches improve the total cholesterol/HDL ratio—a key predictor of cardiovascular health.

Small Dense LDL and Cardiovascular Risk

The speaker highlights the importance of small dense LDL as a significant risk factor for atherosclerosis. He connects dietary habits with the type and density of LDL particles present in the bloodstream.

Conclusions on Health and Diet Relationships

The lecture culminates with a perspective that both health and disease conditions stem from how diet impacts lipid metabolism. There is a clear dichotomy where low-carb diets enhance metabolic health by reducing harmful lipid profiles.

top 1 comments
sorted by: hot top new old
[-] [email protected] 1 points 4 months ago* (last edited 3 days ago)

Notes

Papers Referenced

Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy

The Clinical Biochemistry of Obesity

The Clinical Biochemistry of Obesity—More Than Skin Deep

Association of low carbohydrate diet score with the risk of type 2 diabetes in an Australian population: A longitudinal study

The nutritional geometry of liver disease including non-alcoholic fatty liver disease

Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials

Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies

Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors

A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver

Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study

The mystery of evacetrapib - why are CETP inhibitors failing?

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

Modification of lipoprotein metabolism and function driving atherogenesis in diabetes

Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

LDL cholesterol: controversies and future therapeutic directions

Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.

Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis: The KETO Trial

Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment

Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment

The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets

Notes:

Once damaged (oxidate/glycated) LDL is absorbed by macrophages and not the liver.

  • Anybody who is thinking cholesterol is bad 30 years out of date.
  • Anybody who is thinking LDL is bad is bad 20 years out of date.
  • Anybody who is saying sdLDL is bad is at least 10 years up to date.
  • Anybody who is questioning what makes sdLDL so atherogenic is up to date.

  • lbLDL (large buoyant ) - is good and can be seen in a density analysis
  • sdLDL (small dense) - is atherogenic

lipid energy hypothesis is about energy, not atherogenesis

.

this post was submitted on 02 Feb 2025
1 points (100.0% liked)

Metabolic Health

120 readers
1 users here now

A place to discuss metabolic health research, papers, talks, etc.

This topic can touch upon many people's personal triggers, so please be civil.

Rules

  1. Be nice
  2. Stay on topic
  3. Don't farm rage
  4. Be respectful of other diets, choices, lifestyles!!!!
  5. No Blanket down voting - If you only come to this community to downvote its the wrong community for you

The banner poster in high resolution can be found here

founded 7 months ago
MODERATORS